AMBRIDGE, Mass.--(BUSINESS WIRE)--PixarBio is proud to announce that Laura Morse has joined the Board of Directors as an independent Board Member. PixarBio Corporation, the inventors of NeuroReleaseTM, a morphine strength, non-addictive non opiate pain treatment with expected FDA approval in 2018, is positioning the board for compliance with SEC regulations. Laura Morse will join Chief Executive Officer Frank Reynolds, Chief Administration Officer Katrin Holzhaus, independent Board Member David A. Cass, and independent Board Member Derek Bridges on the Board while serving on the audit and the general & nominating committee.
